Search
Search
多發性骨髓瘤(Multiple myeloma,MM)是漿細胞(plasma cell)惡性增生性疾病。好發年齡在60歲以上,男:女約1. 5:1。在台灣是第三常見的造血系統腫瘤,約占造血系統腫瘤 ...
多發性骨髓瘤(英語:Multiple myeloma、Plasma cell myeloma、Kahler's disease,縮寫:MM)簡稱骨髓瘤(myeloma),是一種存在於骨髓內漿細胞(一種專責製造抗体的 ...
#3. 急診困難診斷:多發性骨髓瘤(multiple myeloma) 許欽銓
多發性骨髓瘤佔所有癌症僅1-2%,但佔血癌比例約達17%。這是一個幾乎發生在高齡者的疾病,平均發病的年齡是66歲,僅有約2%的病人會在40歲以前發病。發病 ...
#4. 認識白血病(Leukemia)-- 多發性骨髓瘤(Multiple myeloma, MM)
多發性骨髓瘤(Multiple myeloma, MM) 是一種骨髓中漿細胞增生的惡性血液疾病。在2012年,MM在美國的發生率約每十萬人有6.3個罹患,佔常見惡性血液疾病 ...
#5. 林自強內科診所- 多發性骨髓瘤(Multiple myeloma - Facebook
以往MM的診斷基本上若找到惡性漿細胞增生的證據(如骨髓切片檢查,異常漿細胞用免疫細胞化學染色CD138(+)Mum-1(+)和血液或尿液中存在有骨髓瘤相關的單株 ...
多發性骨髓瘤(Multiple myeloma, MM, myeloma, plasma cell myeloma, or as Kahler's disease)是一種漿細胞不正常增生,致使侵犯骨髓的一種惡性腫瘤。
#7. 多發性骨髓瘤 - 中文百科知識
多發性骨髓瘤(Multiple myeloma, MM, myeloma, plasma cell myeloma, or as Kahler's disease )是一種漿細胞不正常增生,致使侵犯骨髓的一種惡性腫瘤。
#8. 認識多發性骨髓瘤及淋巴瘤(Multiple Myeloma ... - 長庚醫院
多發性骨髓瘤與淋巴瘤是造血系統癌症中主要的兩種惡性疾患,這. 兩種疾病的治療,近年來迭有突破,多發性骨髓瘤目前雖尚屬不可. 治癒性的疾病,但日新月異的進步,為病 ...
#9. 多发性骨髓瘤_百度百科
由于正常免疫球蛋白的生成受抑,因此容易出现各种细菌性感染。发病率估计为2~3/10万,男女比例为1.6:1,大多患者年龄>40岁。 外文名: multiple myeloma(MM).
#10. 多發性骨髓瘤 - A+醫學百科
多發性骨髓瘤(multiple myeloma,MM)是漿細胞異常增生的惡性腫瘤。一種進行性的腫瘤性疾病.其特徵為骨髓漿細胞瘤和一株完整性的單克隆免疫球蛋白(IgG,IgA,IgD或IgE) ...
#11. multiple myeloma,MM 多發性骨髓瘤- 血液病学医学名词
multiple myeloma,MM 多發性骨髓瘤,是什麽意思,英文怎麽說,中文意思,血液病學醫學名詞-詞匯翻譯,美國LetPub 論文編輯.
#12. Multiple myeloma筆記整理
Multiple myeloma (MM) -Triad 1. Marrow plasmacytosis (>10%) 2. Lytic bone lesion 3. Serum.
#13. 多發性骨髓瘤(Multiple myeloma;MM) 症狀口訣CRAB(螃蟹 ...
多發性骨髓瘤 (Multiple myeloma;MM) 症狀口訣CRAB(螃蟹) 多發性骨髓瘤主要可分為「無症狀」 及「有症狀」兩種,差別在於有沒有伴隨器 官或組織的 ...
#14. 瑞復美膠囊- 藥品字典- 預防/治療 - 華人癌症資訊網
中文 名稱:瑞復美膠囊英文名稱:Lenalidomide藥品:Revlimid藥品分類:抗腫瘤藥品藥物仿單 ... 移植之新診斷多發性骨髓瘤(multiple myeloma,MM)患者的維持治療用藥。
#15. 我如何治疗年轻的多发性骨髓瘤患者 - NCBI
多发性骨髓瘤(multiple myeloma,MM)治疗的历程可分成三个阶段:传统化疗、造血干细胞移植、新药或新药序贯移植时代。传统化疗的完全缓解(CR)率小于10%,中位总体 ...
#16. 多发性骨髓瘤| 西安杨森制药有限公司
多发性骨髓瘤(Multiple Myeloma, MM)是由于单克隆浆细胞恶性增生、广泛浸润并分泌大量单克隆免疫球蛋白(M蛋白)从而引起广泛的骨质破坏,反复感染,贫血,高钙血症、 ...
#17. 多发性骨髓瘤的病理生物学
多发性骨髓瘤(multiple myeloma, MM)是一种恶性浆细胞疾病,约占所有血液系统恶性肿瘤的10%。该病不可治愈,约占血液系统恶性肿瘤死亡病例的20%,占所有癌症死亡病例 ...
#18. multiple myeloma中文 - Artexchange
“myeloma” 中文翻譯: n. (pl. myelomas, -mata ) 【醫“myeloma” 中文翻譯: n. ... 多發性骨髓瘤(Multiple myeloma,MM)是漿細胞(plasma cell)惡性增生性疾病。
#19. plasma cell myeloma 中文 - Mojodor
多發性骨髓瘤(Multiple myeloma, MM, myeloma, plasma cell myeloma, or as Kahler's disease)是一種漿細胞不正常增生,致使侵犯骨髓的一種惡性腫瘤。
#20. multiple myeloma, mm 中文 - 查查綫上辭典
multiple myeloma, mm中文:多發性骨髓瘤…,點擊查查權威綫上辭典詳細解釋multiple myeloma, mm的中文翻譯,multiple myeloma, mm的發音,音標,用法和例句等。
#21. 多发性骨髓瘤_搜狗百科
发病率估计为2~3/10万,男女比例为1.6:1,大多患者年龄>40岁。 主要病因不明. 英文名称multiple myeloma(MM). 主要症状贫血、骨 ...
#22. Multiple myeloma - Symptoms and causes - Mayo Clinic
Learn about this cancer that forms from white blood cells called plasma cells. Multiple myeloma treatments include medications and bone ...
#23. Hema Medical Education Series: Multiple Myeloma (MM)
Hema Medical Education Series: Multiple Myeloma (MM). 110年9月29日(三)19:00:00. 項目, 內容. 時間 ...
#24. 搜尋條件203.0 ,搜尋結果清單如下 - 台灣藥物臨床試驗資訊網
Revlimid 與dexamethasone 合併使用可治療先前已接受至少一種治療失敗之多發性骨髓瘤(multiple myeloma,MM) 患者。
#25. Idecabtagene Vicleucel in Relapsed and Refractory Multiple ...
Despite treatment advances in multiple myeloma, relapses are common. ... and bluebird bio, Cambridge (F.P., M.M.) — all in Massachusetts; ...
#26. 多發性骨髓瘤(MM(多發性骨髓瘤簡稱)) - 中文百科全書
英文名稱:multiple myeloma(MM); 就診科室:血液科; 多發群體:40歲以上,特別是60歲以上的老年人; 常見病因:不明; 常見症狀:貧血、骨痛、腎功能不全、感染、 ...
#27. 多發性骨髓瘤( multiple myeloma )
多發性骨髓瘤(Multiple myeloma, MM, myeloma, plasma cell myeloma)是一種漿細胞(一種專責製造抗體的白血球)不正常增生,致使侵犯骨髓的一種惡性腫瘤(癌症)。
#28. mm 醫學
多發性骨髓瘤(Multiple myeloma,MM)是漿細胞(plasma cell)惡性增生性疾病。 好發年齡在60歲以上,男:女約1. 5:1。 在臺灣是第三常見的造血系統腫瘤,約占造血系統 ...
#29. 不一樣的Plasma | vinaHK健健康康
多發性骨髓瘤英文名稱Multiple Myeloma,簡稱MM,歷史可追溯至西元1844年 ... 血液惡性腫瘤的10分之一,以及其它尚不知的原因,MM的發生率正逐漸上升.
#30. “MM”是“Multiple Myeloma”的缩写,意思是“多发性骨髓瘤”
英文缩写词:MM; 英文单词:Multiple Myeloma; 缩写词中文简要解释:多发性骨髓瘤; 中文拼音:duō fā xìng gǔ suǐ liú; 缩写词流行度:61; 缩写词分类:Medical ...
#31. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment
Treatment of plasma cell neoplasms (including multiple myeloma, monoclonal gammopathy of undetermined significance, and plasmacytoma) ...
#32. Drug Therapy for Multiple Myeloma - American Cancer Society
Many different types of drugs can be used to treat multiple myeloma. ... and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.
#33. Multiple Myeloma and Kidney Disease - Hindawi
Once reversible factors, such as hypercalcemia, have been corrected, the most common cause of severe acute kidney injury (AKI) in MM patients is ...
#34. Multiple myeloma in Australia statistics
The following material has been sourced from the Australian Institute of Health and Welfare Multiple myeloma incorporates ICD-10 cancer ...
#35. Multiple Myeloma | Johns Hopkins Kimmel Cancer Center
In multiple myeloma, cancerous plasma cells (myeloma cells) are found in the bone marrow, the spongy tissue inside bones that manufactures blood cells. When ...
#36. Smoldering Multiple Myeloma: Symptoms, Causes, Diagnosis ...
Smoldering multiple myeloma is not actually cancer, but a pre-cancerous condition signalling a high risk for blood cancer.
#37. N 의학정보( 다발성 골수종 [multiple myeloma, MM] ) - 서울 ...
[multiple myeloma, MM]. 한 줄 설명. 백혈구의 한 종류인 B림프구의 최종 성숙 단계인 형질세포에서 발생하는 혈액암. 진료과 ...
#38. Treatment by Cancer Type - NCCN
Multiple Myeloma. Version: 4.2022. Myelodysplastic Syndromes. Version: 2.2022. Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Fusion Genes.
#39. Andrew Souto on LinkedIn: A scalable high-throughput ...
clonoSEQ® is the first and only FDA-cleared assay for minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL), multiple myeloma (MM) and B-cell ...
#40. Phase-Specific and Lifetime Costs of Multiple Myeloma ...
Importance Health care costs associated with diagnosis and care among older adults with multiple myeloma (MM) are substantial, with cost of ...
#41. myeloma cell | 科學Online - 國立臺灣大學
單株抗體—HAT培養基(HAT medium) 國立臺灣大學醫學系林祐民、臺北市立建國高中劉翠華教師. 關於單株抗體(monoclonal antibody)的背景與原理請參閱國科會高瞻計畫 ...
#42. Multiple Myeloma - Medscape Reference
Multiple myeloma (MM) is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance ...
#43. Multiple myeloma (MM) - Google 圖書結果
#44. Multiple Myeloma - 第 197 頁 - Google 圖書結果
The Etiology and Pathophysiology of Multiple Myeloma Loredana Santo and ... of novel agents has changed the landscape of multiple myeloma (MM) outcomes, ...
#45. Multiple Myeloma: A Quick Reflection on the Fast Progress
Osteolytic bone disease in multiple myeloma (MM) is a common event. Already at diagnosis, approximately eighty percent of patients present with abnormal ...
#46. Multiple Myeloma: Diagnosis and Treatment
Biological Therapy for Multiple Camilo Ayala-Breton, Stephen J. Russell, M.A. ... relapsed or relapsed/refractory multiple myeloma (MM): promising activity ...
#47. Multiple Myeloma and Related Disorders - 第 46 頁 - Google 圖書結果
This is also true for multiple myeloma (MM),1 although cytogenetic studies of MM cells are often hampered by the low mitotic rate of the myelomatous clone.
#48. Immunotherapy in Multiple Myeloma - 第 138 頁 - Google 圖書結果
Their current application in multiple myeloma (MM) is rather uncertain, as discordant results have been reported by distinct research groups concerning ...
#49. Multiple Myeloma - A New Era of Treatment Strategies
The interactions of multiple myeloma (MM) cells with bone cells within the bone marrow microenvironment lead to unbalance of the osteoclast (OC)/osteoblast ...
#50. Advances in Biology and Therapy of Multiple Myeloma: Volume ...
... proteasome immunoproteasome expression, 172, 173 MLN2238, 169 in MM, 158 COX-2. ... 79 immune status, MM (see Multiple myeloma (MM)) immunodeficiency, ...
#51. Neoplastic Diseases of the Blood - 第 659 頁 - Google 圖書結果
Bortezomib/dexamethasone versus VAD as induction prior to autologous stem cell transplantion (ASCT) in previously untreated multiple myeloma (MM): updated ...
#52. Multiple myeloma: the (r)evolution of current therapy and a ...
Over the past 20 years, the regulatory approval of several novel agents to treat multiple myeloma (MM) has prolonged median patient survival ...
multiple myeloma mm中文 在 林自強內科診所- 多發性骨髓瘤(Multiple myeloma - Facebook 的推薦與評價
以往MM的診斷基本上若找到惡性漿細胞增生的證據(如骨髓切片檢查,異常漿細胞用免疫細胞化學染色CD138(+)Mum-1(+)和血液或尿液中存在有骨髓瘤相關的單株 ... ... <看更多>